From its 17-year development cycle…
From its 17-year development cycle through to its commercial launch, [...]
From its 17-year development cycle through to its commercial launch, [...]
Immutep and the Australian biotech’s investors have been caught off [...]
Simtra BioPharma Solutions was issued a warning letter by the [...]
The FDA has rejected Hyloris Pharmaceuticals’ antiviral valacyclovir, an oral [...]
Drugs like Wegovy and Zepbound have been hailed as miracle [...]
Years after BioNTech’s CEO Uğur Şahin, M.D. and chief medical [...]
Eli Lilly is making investments in China, Japan and South [...]
Artificial intelligence (AI) now features prominently in boardroom and executive [...]
As pharmas like Eli Lilly and Roche bolster their biotech [...]
Vistagen Therapeutics is doubling down on its lead social anxiety [...]